Press Release: Clontech : Takara Bio Announces the Launch of Human iPSC-Derived Beta Cells for Drug Screening and Diabetes Research

MOUNTAIN VIEW, Calif., Aug. 24, 2016 /PRNewswire/ -- Takara Bio USA, Inc., which specializes in human induced pluripotent stem cell (hiPSC)-derived cells and medias for scale-up and differentiation, has expanded its offering of tools for drug discovery and disease modeling. Takara Bio...